These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 23592327)

  • 1. Photostability of crystalline versus amorphous nifedipine and nimodipine.
    Grooff D; Francis F; De Villiers MM; Ferg E
    J Pharm Sci; 2013 Jun; 102(6):1883-1894. PubMed ID: 23592327
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Co-Stabilization of Amorphous Pharmaceuticals-The Case of Nifedipine and Nimodipine.
    Knapik-Kowalczuk J; Tu W; Chmiel K; Rams-Baron M; Paluch M
    Mol Pharm; 2018 Jun; 15(6):2455-2465. PubMed ID: 29738666
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preparation and transformation of true nifedipine polymorphs: investigated with differential scanning calorimetry and X-Ray diffraction pattern fitting methods.
    Grooff D; Liebenberg W; De Villiers MM
    J Pharm Sci; 2011 May; 100(5):1944-57. PubMed ID: 21259235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FTIR spectroscopic study of poly(ethylene glycol)-nifedipine dispersion stability in different relative humidities.
    Iqbal WS; Chan KL
    J Pharm Sci; 2015 Jan; 104(1):280-4. PubMed ID: 25410816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surface-enhanced crystallization of amorphous nifedipine.
    Zhu L; Wong L; Yu L
    Mol Pharm; 2008; 5(6):921-6. PubMed ID: 19434917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular mobility-based estimation of the crystallization rates of amorphous nifedipine and phenobarbital in poly(vinylpyrrolidone) solid dispersions.
    Aso Y; Yoshioka S; Kojima S
    J Pharm Sci; 2004 Feb; 93(2):384-91. PubMed ID: 14705195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In-situ determination of crystallization kinetics in ASDs via water sorption experiments.
    Luebbert C; Sadowski G
    Eur J Pharm Biopharm; 2018 Jun; 127():183-193. PubMed ID: 29477357
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frozen in Time: Kinetically Stabilized Amorphous Solid Dispersions of Nifedipine Stable after a Quarter Century of Storage.
    Theil F; Anantharaman S; Kyeremateng SO; van Lishaut H; Dreis-Kühne SH; Rosenberg J; Mägerlein M; Woehrle GH
    Mol Pharm; 2017 Jan; 14(1):183-192. PubMed ID: 28043131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug-polymer interaction and its significance on the physical stability of nifedipine amorphous dispersion in microparticles of an ammonio methacrylate copolymer and ethylcellulose binary blend.
    Huang J; Wigent RJ; Schwartz JB
    J Pharm Sci; 2008 Jan; 97(1):251-62. PubMed ID: 17724668
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polarographic study of the photodecomposition of nimodipine.
    Zanocco AL; Díaz L; López M; Nuñez-Vergara LJ; Squella JA
    J Pharm Sci; 1992 Sep; 81(9):920-4. PubMed ID: 1432641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of the physical stability of amorphous felodipine and nifedipine systems.
    Marsac PJ; Konno H; Taylor LS
    Pharm Res; 2006 Oct; 23(10):2306-16. PubMed ID: 16927182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization and stability of solid dispersions based on PEG/polymer blends.
    Bley H; Fussnegger B; Bodmeier R
    Int J Pharm; 2010 May; 390(2):165-73. PubMed ID: 20132875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Real-time in situ X-ray micro-computed tomography study of the effect of impurities on the crystallization of amorphous nifedipine.
    Amano Y; Misawa T; Miyazaki T; Ando D; Koide T; Izutsu KI; Kanazawa H; Hanaoka K; Yamamoto E
    J Pharm Biomed Anal; 2023 Mar; 226():115248. PubMed ID: 36645986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vitrification from solution in restricted space: formation and stabilization of amorphous nifedipine in a nanoporous silica xerogel carrier.
    Godec A; Maver U; Bele M; Planinsek O; Srcic S; Gaberscek M; Jamnik J
    Int J Pharm; 2007 Oct; 343(1-2):131-40. PubMed ID: 17590546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation of an amorphous sodium furosemide salt improves solubility and dissolution rate and leads to a faster Tmax after oral dosing to rats.
    Nielsen LH; Gordon S; Holm R; Selen A; Rades T; Müllertz A
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):942-51. PubMed ID: 24075980
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stabilization of solid dispersions of nimodipine and polyethylene glycol 2000.
    Urbanetz NA
    Eur J Pharm Sci; 2006 May; 28(1-2):67-76. PubMed ID: 16472995
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An investigation of nifedipine miscibility in solid dispersions using Raman spectroscopy.
    Keratichewanun S; Yoshihashi Y; Sutanthavibul N; Terada K; Chatchawalsaisin J
    Pharm Res; 2015 Jul; 32(7):2458-73. PubMed ID: 25673042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thermal stability of 1,4-dihydropyridine derivatives in solid state.
    Marciniec B; Ogrodowczyk M
    Acta Pol Pharm; 2006; 63(6):477-84. PubMed ID: 17438863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A calorimetric investigation of thermodynamic and molecular mobility contributions to the physical stability of two pharmaceutical glasses.
    Zhou D; Grant DJ; Zhang GG; Law D; Schmitt EA
    J Pharm Sci; 2007 Jan; 96(1):71-83. PubMed ID: 17031846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural characterization, physicochemical properties, and thermal stability of three crystal forms of nifedipine.
    Caira MR; Robbertse Y; Bergh JJ; Song M; De Villiers MM
    J Pharm Sci; 2003 Dec; 92(12):2519-33. PubMed ID: 14603498
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.